Schedule 13G ownership disclosure
Ironwood Pharmaceuticals Inc
Class A Common Stock, Par Value $0.001 Per Share · CUSIP: 46333X108
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Pacer US Small Cap Cash Cows ETF
Shares: 1,789,098 · Class: 1.12%
- Pacer US Small Cap Cash Cows Growth Leaders ETF
Shares: 0 · Class: 0%
- Pacer Advisors, Inc.
Shares: 1,789,098 · Class: 1.12%
- Joe M. Thomson
Shares: 1,789,098 · Class: 1.12%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000894189-25-003446
- Form type
- SCHEDULE 13G/A
- Filer
- IRONWOOD PHARMACEUTICALS INC
- CIK
- CIK 1446847
- Filed
- May 02, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership